SPIA
PLXP

Steward Partners Investment Advisory’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Steward Partners Investment Advisory’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-43,875
Closed -$123 – 3491
2023
Q2 		$123 Hold
43,875
– – ﹤0.01% 3260
2023
Q1 		$5.71K Sell
43,875
-1,000
-2% -$203 ﹤0.01% 2743
2022
Q4 		$7.36K Sell
44,875
-15,480
-26% -$6.48K ﹤0.01% 2636
2022
Q3 		$39K Sell
60,355
-5,000
-8% -$7.37K ﹤0.01% 1918
2022
Q2 		$159K Sell
65,355
-4,793
-7% -$13.3K ﹤0.01% 1300
2022
Q1 		$283K Buy
70,148
+10,700
+18% +$58.7K ﹤0.01% 1164
2021
Q4 		$476K Buy
59,448
+18,300
+44% +$215K 0.01% 950
2021
Q3 		$794K Buy
41,148
+30,555
+288% +$534K 0.01% 736
2021
Q2 		$146K Buy
10,593
+1,500
+16% +$17.8K ﹤0.01% 1807
2021
Q1 		$82.1K Buy
+9,093
New +$66.5K ﹤0.01% 1715
2018
Q3 		– Sell
-75
Closed – – 2748
2018
Q2 		$0 Buy
+75
New +$306 ﹤0.01% 2578

Steward Partners Investment Advisory's PLXP Position: Q3 2023 in Review

Steward Partners Investment Advisory sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2023, closing a stake of 43,875 shares — an estimated $123 sold.

Steward Partners Investment Advisory first reported a position in PLXP in Q2 2018 and held it in 11 quarters. The position peaked at $794K in Q3 2021. 1 fund tracked by Wall St. Rank holds PLXP as of Q3 2023.

  • Steward Partners Investment Advisory reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 43,875 PLx Pharma Inc. Common Stock shares in Q3 2023, an estimated $123.
  • Steward Partners Investment Advisory first reported a position in PLx Pharma Inc. Common Stock in Q2 2018 and held it in 11 quarters.
  • Steward Partners Investment Advisory's PLx Pharma Inc. Common Stock position peaked at $794K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2023.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2023, filed 13 Nov 2023.